Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka

References

• Flegr J, Prandota J, Sovičková M, Israili ZH. Toxoplasmosis – a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9:1–22. doi:10.1371/e90203.
   Google Scholar
• Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii from animals to humans. Int J Parasitol. 2000;30:1217–1258.10.1016/S0020-7519(00)00124-7
   PubMed Web of Science ®Google Scholar
• Holliman RE. Toxoplasmosis. In: Cook GC, Alimuddin Zumla, editors. Mansons tropical diseases, London: Saunders Elsevier; 2009. 1367–73.
   Google Scholar
• Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. The Lancet. 1999;353:1829–1833.10.1016/S0140-6736(98)08220-8
   PubMed Web of Science ®Google Scholar
• Torgerson, PR, Mastroiacovo, P. The global burden of congenital toxoplasmosis: a systematic review. Geneva: Bull. World Health Organization; 2013.
   Google Scholar
• Ashburn D. History and general epidemiology. Human toxoplasmosis. Edited by Oxford: Oxford University press; 1992.
   Google Scholar
• Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554–66. doi:10.1086/590149.
   PubMed Web of Science ®Google Scholar
• Singh S, Munawwar A, Rao S, Mehta S, Hazarika NK. Serologic prevalence of Toxoplasma gondii in Indian women of child bearing age and effects of social and environmental factors. PLoS Negl Trop Dis. 2014;8:1–9. doi:10.1371/e90203.
   Google Scholar
• Kulasena VA, Rajapakse RP, Dubey JP, Dayawansa PN, Premawansa S. Seroprevalence of T. gondii in cats from Colombo, Sri Lanka. J Parasitology. 2011;97:152.10.1645/GE-2640.1
   PubMed Web of Science ®Google Scholar
• Dubey JP, Rajapakse RP, Ekanayake DK, Sreekumar C, Lehmann T. Isolation and molecular characterization of Toxoplasma gondii from chickens from Sri Lanka. J Parasitol. 2005;91:1480–2.10.1645/GE-479R.1
   PubMed Web of Science ®Google Scholar
• Dorny P, Van Aken D. Seroprevalence of T. gondii antibodies in goats in Sri Lanka. Ann Trop Med Parasitol. 1992;86:83–5.
   PubMed Web of Science ®Google Scholar
• De Silva S, Kulasiri C, Sugathapala KM, Amerasinghe DKC. A survey of indirect haemagglutination test antibodies against Toxoplasma gondii in neonates in Ceylon. Ceylon J Med Sci. 1972;21:1–8.
   Google Scholar
• Ekanayake S, Kurukulasuriya NT. Prevalence of antibodies to Toxoplasma gondii in pregnant women. Kandy Med J. 1992;4:36–40.
   Google Scholar
• Samarasinghe S. Prevalence of Toxoplasma gondii antibodies in healthy pregnant mothers and pregnant mothers with a bad obstetric history in Sri Lanka. In: Asian Parasitology. Vol 4. Toxoplasmosis and Babesiosis in Asia. The Federation of Asian Parasitologists, AAA Committee Japan; 2005. p. 5–10. http://pgim.srilankahealthrepository.org/handle/123456789/6387.
   Google Scholar
• Subasinghe SDLP, Karunaweera ND, Kaluarachchi A, Abayaweera CA, Gunatilake MH, Ranawaka J, et al. Toxoplasma gondii seroprevalence among two selected groups of women. SLJID. 2011;1: 9–17.
   Google Scholar
• Silva MG, Vinaud MC, Castro AM. Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014. Plos One. 2015;10(11):e0141700. doi: 10.1371.10.1371/journal.pone.0141700
   Google Scholar
• Galvan-Ramirez MdeL, Troyo R, Roman S, Calvillo-Sanchez C, Bernal-Redondo R. A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population. Parasit Vectors. 2012; 5:271. doi: 10.1186/1756-3305-5-271.
   PubMed Web of Science ®Google Scholar
• Jones JL. Toxoplasma gondii Infection in the United States: Seroprevalence and Risk Factors. Am J Epidemiol. 2001;154:357–365.10.1093/aje/154.4.357
   PubMed Web of Science ®Google Scholar
• Nowakowska D, Stray-Pedersen B, Spiewak E, Sobala W, Małafiej E, Wilczyński J. Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland; a decreasing trend in the younger population. Clin Microbiol Infect. 2006;12(9): 913–7.10.1111/j.1469-0691.2006.01513.x
   PubMed Web of Science ®Google Scholar
• Berger F, Goulet V, Le Strat Y, Desenclos JC. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Rev Epidemiol Sante Publique. 2009;57:241–8.10.1016/j.respe.2009.03.006
   PubMed Web of Science ®Google Scholar
• Lopes AP, Dubey JP, Moutinho O, Gargate MJ, Vilares A, Rodrigues, et al. Seroepidemiology of Toxoplasma gondii infection in women from the North of Portugal in their childbearing years. Epidemiol Infect. 2012;140(5):872–7.10.1017/S0950268811001658
   PubMed Web of Science ®Google Scholar
• Flatt A, Shety N. Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk factors in an ethnically diverse population. Eur J Public Health. 2012;23:648–52.
   PubMed Web of Science ®Google Scholar
• Lebech M, Larsen SO, Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Infect Dis. 1993;25(6):751–6.10.3109/00365549309008574
   PubMed Web of Science ®Google Scholar
• Ayi I, Edu SA, Apea-Kubi KA, Boamah D, Bosompem KM, Edoh D. Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater accra region of ghana. Ghana Med J. 2009;43(3):107–14.
   PubMedGoogle Scholar
• Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M. et al. Seroepedimiolgy of Toxoplasma gondii infection in women of child bearing age in central Ethiopia. BMC Infect Dis. 2013;13:101. doi: 10.1186/1471-2334-13-101.
   PubMed Web of Science ®Google Scholar
• Doudou Y, Renaud P, Coralie L, Jacqueline F, Hypolite S, Hypolite M, et al. Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasha, Democratic republic of Congo. Asian Pac J Trop Biomed. 2014;4:69–74.10.1016/S2221-1691(14)60211-2
   PubMedGoogle Scholar
• Han K, Shin DW, Lee TY, Lee YH. Seroprevalence of Toxoplasma gondii infection and risk factors associated with seropositivity of pregnant women in Korea. J Parasitol. 2008;94:963–5.10.1645/GE-1435.1
   PubMed Web of Science ®Google Scholar
• Hung CS, Su HW, Lee YL, Weng HW, Wang YC, Naito T, et al. Seroprevalence, Seroconversion and Risk Factors for Toxoplasmosis among Pregnant Women in Taipei, Taiwan. Jpn J Infect Dis. 2015;68(4):312–7.10.7883/yoken.JJID.2014.263
   PubMed Web of Science ®Google Scholar
• Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-toxoplasma antibody prevalence, primary infection rate and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol. 2012;19:365–7.10.1128/CVI.05486-11
   PubMed Web of Science ®Google Scholar
• Pal RA, Qayyum M, Yaseen M. Seroprevalence of antibodies to Toxoplasma gondii, with particular reference to obstetric history of patients in Rawalpindi-Islamabad, Pakistan. J Pak Med Assoc. 1996;46(3):56–8.
   PubMedGoogle Scholar
• Ashrafunnessa, Khatun S, islam MN, Huq T. Seroprevalence of toxoplasma antibodies among the antenatal population in Bangladesh. J Obstet Gynaecol Res. 1998; (2):115–9.
   PubMedGoogle Scholar
• Nijem KA-AS. Seroprevalence and associated risk factors of toxoplasmosis in pregnant women in Hebron district. Palestine East. Mediterr. Health J. 2009;15:1279–84.
   Google Scholar
• Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005 Jun 15;5:66.10.1186/1471-2458-5-66
   PubMed Web of Science ®Google Scholar
• Ishaku BAI, Umoh J, Lawal I, Randawa A. Seroprevalence and risk factors for toxoplasmosis among antenatal women in Zaria. Nigeria Res J Medicine Sci. 2009;4:483–488.
   Google Scholar
• Chiang TY, Kuo MC, Chen CH, Yang JY, Kao CF, Ji DD, et al. Risk factors for acute Toxoplasma gondii diseases in Taiwan: a population-based case-control study. PLoS One. 2014;9:1–7. doi10.1371/e90880
   Google Scholar
• Fan CK, Lee LW, Liao CW, Huang YC, Lee YL, Chang YT, et al. Toxoplasma gondii infection: relationship between seroprevalence and risk factors among primary schoolchildren in the capital areas of Democratic Republic of São Tomé and Príncipe, West Africa. Parasit Vectors. 2012 Jul 13;5:141.10.1186/1756-3305-5-141
   Web of Science ®Google Scholar
• Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. J Parasitol. 1995;81(3):410–415.10.2307/3283823
   PubMed Web of Science ®Google Scholar
• Dubey JP. Sources of Toxoplasma gondii infection in pregnancy. BMJ. 2000;321:127–128.10.1136/bmj.321.7254.127
   PubMed Web of Science ®Google Scholar
• Abu EK, Boampong JN, Ayi I, Ghartey-Kwansah G, Afoakwah R, Nsiah P., et al. Infection risk factors associated with seropositivity for Toxoplasma gondii in a population-based study in the Central Region, Ghana. Epidemiol Infect. 2014;6:1–9.
   Google Scholar
• Alvarado-Esquivel C, Pacheco-Vega SJ, Hernandez-Tinoco J, Salcedo-Jaguez M, Sanchez-Anguiano LF, Berumen-Segovia LO, et al. Toxoplasma gondii infection in interstate truck drivers: a case-control seroprevalence study. Parasit Vectors. 2015;8:77.10.1186/s13071-015-0690-z
   PubMed Web of Science ®Google Scholar
• Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol. 1994;11:57–62.10.1055/s-2007-994537
   PubMed Web of Science ®Google Scholar